Research Insight
Research Insight
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a...
Research Insight
Generative AI Practitioners in Healthcare Prioritize Industry-Specific and Task-Specific Models as Budgets Surge 300%, New John Snow Labs Survey Finds
John Snow Labs, the AI for healthcare company announced the findings of the inaugural Generative AI in Healthcare Survey. Conducted by Gradient Flow, the research...
Research Insight
New Brigham Research Highlights Combining Prostate MRI with a Blood Test to Avoid Unnecessary Prostate Biopsies
A new meta-analysis by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that doctors and patients...
News
Preliminary Clinical Trial Results Show ‘Dramatic and Rapid Regression’ of Glioblastoma after Next Generation CAR-T Therapy
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the...
Research Insight
Research Spotlight: A Two-Part Priming Strategy to Increase the Sensitivity of Liquid Biopsies
What Question Were You Investigating with this Study?
Liquid biopsies, such as blood draws, can allow for the noninvasive diagnosis and monitoring of disease. The number...
Research Insight
Lung Fibrosis is Seen Reversed in COVID Patients: Says Expert
Chronic Obstructive Pulmonary Disease (COPD) is currently the third leading cause of death globally. There are 300 million current cases of COPD in the world....
Research Insight
Monoclonal Antibody Therapy 100% prevents Severe Disease and Deaths, says AIG Hospitals Study
The Monoclonal Antibody drug cocktail gained global attention as a miracle cure for COVID-19 ever since it got administered on ex-US president Donald Trump, but...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.